Tower Research Capital LLC (TRC) - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 39 filers reported holding ATYR PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q4 2018$0
-100.0%
100
-99.3%
0.00%
-100.0%
Q1 2018$40,000
-2.4%
14,956
+27.0%
0.00%
-40.0%
Q4 2017$41,000
+1950.0%
11,777
+948.7%
0.01%
Q4 2016$2,000
-50.0%
1,123
-25.6%
0.00%
Q3 2016$4,000
-50.0%
1,509
-48.2%
0.00%
-100.0%
Q2 2016$8,0002,911
+291000.0%
0.00%
Q1 2016$0
-100.0%
1
-99.9%
0.00%
-100.0%
Q3 2015$12,000
+1100.0%
1,215
+1520.0%
0.00%
Q2 2015$1,000750.00%
Other shareholders
ATYR PHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$3,930,0004.66%
EcoR1 Capital, LLC 976,986$2,101,0000.67%
TANG CAPITAL MANAGEMENT LLC 279,425$601,0000.32%
Rock Springs Capital Management LP 475,000$1,021,0000.07%
Quotient Investors, LLC 22,200$48,0000.03%
Alyeska Investment Group, L.P. 1,072,108$2,305,0000.02%
TIVERTON ASSET MANAGEMENT LLC 95,318$205,0000.01%
RIVERHEAD CAPITAL MANAGEMENT LLC 79,677$171,0000.01%
Acrospire Investment Management LLC 12,683$27,0000.01%
Glen Harbor Capital Management LLC 179,724$386,0000.01%
View complete list of ATYR PHARMA INC shareholders